Follow
Mikel García-Puga
Mikel García-Puga
Investigador Biomédico, Biodonostia
Verified email at biodonostia.org
Title
Cited by
Cited by
Year
Muscle wasting in myotonic dystrophies: a model of premature aging
AJ Mateos-Aierdi, M Goicoechea, A Aiastui, R Fernández-Torrón, ...
Frontiers in aging neuroscience 7, 125, 2015
1192015
SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression
JC Santos, E Carrasco-Garcia, M Garcia-Puga, P Aldaz, M Montes, ...
Cancer research 76 (22), 6735-6746, 2016
1162016
Paradoxical role of SOX2 in gastric cancer
E Carrasco-Garcia, JC Santos, I Garcia, M Brianti, M García-Puga, ...
American journal of cancer research 6 (4), 701, 2016
522016
Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation
R Fernández-Torrón, M García-Puga, JI Emparanza, M Maneiro, ...
Neurology 87 (12), 1250-1257, 2016
492016
Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin
M García-Puga, A Saenz-Antoñanzas, R Fernández-Torrón, ...
Aging (Albany NY) 12 (7), 6260, 2020
392020
SOX9 promotes tumor progression through the axis BMI1-p21CIP
P Aldaz, M Otaegi-Ugartemendia, A Saenz-Antonanzas, M Garcia-Puga, ...
Scientific reports 10 (1), 357, 2020
392020
Towards precision medicine: linking genetic and cellular heterogeneity in gastric cancer
E Carrasco-Garcia, M García-Puga, S Arevalo, A Matheu
Therapeutic advances in medical oncology 10, 1758835918794628, 2018
202018
Targeting myotonic dystrophy type 1 with metformin
M García-Puga, A Saenz-Antoñanzas, A Matheu, A López de Munain
International journal of molecular sciences 23 (5), 2901, 2022
182022
Chaperone-mediated autophagy controls proteomic and transcriptomic pathways to maintain glioma stem cell activity
J Auzmendi-Iriarte, M Otaegi-Ugartemendia, E Carrasco-Garcia, ...
Cancer research 82 (7), 1283-1297, 2022
142022
Therapeutic relevance of SOX9 stem cell factor in gastric cancer
E Carrasco-Garcia, M Álvarez-Satta, M García-Puga, ML Ribeiro, ...
Expert Opinion on Therapeutic Targets 23 (2), 143-152, 2019
132019
Senescence plays a role in myotonic dystrophy type 1
M García-Puga, A Saenz-Antoñanzas, G Gerenu, A Arrieta-Legorburu, ...
JCI insight 7 (19), 2022
82022
∆Np73 is capable of inducing apoptosis by co-ordinately activating several BH3-only proteins
D Sánchez-Carrera, M García-Puga, L Yáñez, Í Romón, C Pipaón
Bioscience Reports 35 (3), 2015
52015
Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study
Y Wang, A Best, R Fernández‐Torrón, R Alsaggaf, M Garcia‐Puga, ...
Annals of Clinical and Translational Neurology 7 (1), 126-131, 2020
42020
Biallelic variants in SNUPN cause a limb girdle muscular dystrophy with myofibrillar-like features
P Iruzubieta, A Damborenea, M Ioghen, S Bajew, R Fernandez-Torrón, ...
Brain, awae046, 2024
12024
Nuevas estrategias terapéuticas en la Distrofia Miotónica tipo 1 basadas en los mecanismos moleculares del envejecimiento y del cáncer
M García Puga
Universidad del País Vasco, 2021
2021
Impact of Stem Cell Genes in Gastric Cancer
E Carrasco-Garcia, M García-Puga, M Moreno, N Sampron, S Arevalo, ...
Gastric Cancer, 2017
2017
Impact of SOX Stem Cell Factors in Gastric Cancer
E Carrasco-Garcia, J Carvalho-Santos, M García-Puga, N Sampron, ...
2016
The system can't perform the operation now. Try again later.
Articles 1–17